DJIA 16,501.65 -12.72 -0.08%
NASDAQ 4,126.97 0.00 0.00%
S&P 500 1,875.39 -4.16 -0.22%
market minute promo

AVANIR PHARMACEUTICALS

NASDAQ: AVNR

3.47 -0.13 (-3.61%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AVNR $3.47 -3.61%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.61
Previous Close $3.60
Daily Range $3.46 - $3.64
52-Week Range $2.62 - $6.00
Market Cap $528.5M
P/E Ratio -7.06
Dividend (Yield) $0.00 (0.0%)
Volume 1,248,629
Average Daily Volume 2,118,693
Current FY EPS -$0.29

Sector

Healthcare

Industry

Drugs

AVANIR PHARMACEUTICALS (AVNR) Description

A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases. Website: http://www.avanir.com/

News & Commentary

Avanir Pharmaceuticals Inc.: What Investors Must Watch in 2014

A big mid-stage disappointment sent Avanir's (AVNR) shares tumbling, but the future may not be as bad as some fear.

Avanir's AVP-825 under FDA Review - Analyst Blog

Morning Market Movers

UPDATE: Avanir Pharmaceuticals Announces Acceptance of New Drug Application for AVP-825 for the Acut

UPDATE: Avanir Pharmaceuticals Announces Acceptance of New Drug Application for AVP-825 for the Acute Treatment of Migraine

Avanir Provides New Data - Analyst Blog

Avanir Provides New Data - Analyst Blog

Avanir Pharmaceuticals Announces Appointment of Mark Corrigan to Board of Directors

Notable Two Hundred Day Moving Average Cross - AVNR

Avanir (AVNR) Catches Eye: Stock Soars 16.3% - Tale of the Tape

Thursday's ETF Movers: ILF, XPH

Top Biotech Stocks Under $5 With Huge Potential Upside

Avanir Pharmaceuticals (AVNR) Jumps: Stock Moves 11.7% Higher - Tale of the Tape

See More AVNR News...

AVNR's Top Competitors

AVNR $3.47 (-3.61%)
Current stock: AVNR
JNJ $100.22 (0.04%)
Current stock: JNJ
NVS $86.17 (-0.45%)
Current stock: NVS
RHHBY $36.22 (-0.14%)
Current stock: RHHBY